Thomapyrin

Quick links to important sections

Thomapyrin

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Thomapyrin

Quick Facts

Property Description
Active Ingredients Acetaminophen, Acetylsalicylic acid, Caffeine
Form Oral tablets
Pharmacological Class Combination Analgesic, Antipyretic
Common Use Symptomatic relief of acute pain and fever
Type Fixed-dose combination product

The Core Identity and Classification of Thomapyrin

Thomapyrin is fundamentally defined as a Combination Analgesic and contains agents derived from the Non-steroidal anti-inflammatory drug (NSAID) class, functioning as a multicomponent medicinal product for the relief of general discomforts. It is a chemically synthesized, fixed-dose combination product readily available as an Over-the-Counter (OTC) medicine. The product is manufactured as an oral tablet, intended solely for the oral route of administration, and serves as a primary option for self-treatment of acute symptoms. This three-component formulation is widely clinically recognized for its efficacy in treating headaches and similar acute discomforts.

Composition: The Three Active Ingredients and Synergy

The composition of Thomapyrin includes three distinct active ingredients [INN]: Acetylsalicylic acid (Aspirin), Acetaminophen (Paracetamol), and Caffeine. This particular combination of analgesics with a stimulant is specifically designed to achieve a heightened therapeutic outcome. The preparation's design utilizes the Caffeine component as an analgesic adjuvant, a substance utilized to enhance and accelerate the effectiveness of the primary pain relievers, Acetylsalicylic acid and Acetaminophen. In this combination, the addition of Caffeine is utilized to increase the speed and power of the pain relief provided by Aspirin and Acetaminophen.

General Purpose and High-Level Action

The core purpose of Thomapyrin is to provide rapid, broad-spectrum symptomatic relief by effectively addressing both the sensation of pain and the presence of fever. It functions through a dual-mode action: Acetylsalicylic acid and Acetaminophen work to inhibit the signaling chemicals that cause discomfort, while the Caffeine helps enhance the body's response, leading to effective overall symptomatic mitigation. This specific formulation is intended to offer superior efficacy compared to the single active ingredients alone, making it a well-established choice for individuals seeking relief from acute discomforts like tension headaches. This combination product is designed to be more effective for common acute discomforts than the use of a single active ingredient.

What side effects are possible with Thomapyrin?

Possible Side Effects and Safety Information

The official safety profile for the Acetaminophen, Acetylsalicylic acid, and Caffeine combination is derived from the risks associated with its three components, detailing adverse reactions classified by frequency and affected organ system. This profile addresses both common occurrences and rare, serious safety constraints documented in regulatory labeling.

Adverse Reaction Classification

Side effects are categorized by frequency in regulatory documents:

Classification Examples of Documented Effects
Common Abdominal pain, Dyspepsia, Nausea, Vomiting, Dizziness, Heartburn.
Rare Gastrointestinal ulcers and bleeding, Tachycardia, Vertigo, Agitation, Hyperhidrosis.
Very Rare Elevated transaminases (Liver dysfunction), Renal dysfunction, Gastrointestinal perforation.

These effects are grouped into official System-Organ Classes, including Gastrointestinal Tract Disorders, Nervous System Disorders, Cardiac Disorders, and Hepatic and Renal Disorders.

Serious Adverse Reactions and Safety Constraints

Official labeling mandates specific considerations for serious events. There is a documented risk of Severe Liver Damage or acute liver failure associated with the Acetaminophen component. The Acetylsalicylic acid component carries a risk of serious Gastrointestinal Ulceration, Bleeding, and Perforation. Furthermore, the label notes the risk of Reye's Syndrome associated with Acetylsalicylic acid use in children and adolescents during viral illness.

Safety is defined by constraints tied to the patient's condition and exposure. The product is officially contraindicated in severe hepatic or renal failure and during the third trimester of pregnancy. Long-term use is associated with the risk of Medication Overuse Headache and potential Analgesic Nephropathy.

Overdose and Emergency Response

The official regulatory overdose profile for this combination product details manifestations that reflect the combined toxicological effects of its three active ingredients. Documented presentations include systemic signs such as nausea, vomiting, diaphoresis, and fever, alongside neurological symptoms like tinnitus, confusion, restlessness, and tremor. Severe or life-threatening outcomes explicitly listed in regulatory documents are hepatic necrosis, acute liver failure, profound metabolic acidosis, coma, and convulsions. The potential for dose-dependent hepatotoxicity is a primary concern with the Acetaminophen component.

Immediate medical attention is required for any suspected overdose, and hospitalization for continuous monitoring is mandated, even if initial symptoms are absent. The regulatory basis for management specifies that N-acetylcysteine (NAC) is the specific antidote for Acetaminophen toxicity, but no specific antidote is known for the Salicylate or Caffeine components. Supportive measures include gastric decontamination (e.g., activated charcoal) and correction of fluid/electrolyte imbalances. Monitoring protocols require serial measurement of plasma paracetamol and salicylate levels and liver function tests. Increased risk of severe outcomes is officially noted for patients with pre-existing hepatic or renal impairment.

Therapeutic Uses of Thomapyrin

What Thomapyrin Treats: Main Uses and Benefits

The medication is considered relevant across therapeutic domains involving symptoms related to physical discomfort and heightened symptomatic responses. This fixed-dose combination is commonly used for the symptomatic management of acute headaches, including the discomfort of tension headaches and the pronounced pain associated with migraine attacks (with or without aura).

It is also commonly used to help with mild to moderately severe pain in acute situations, such as toothache or menstrual pain (dysmenorrhea). Furthermore, the combination may assist with reducing symptoms related to systemic imbalance, specifically fever and the accompanying general discomfort of cold and flu-like infections.

Applied in contexts where multiple symptoms occur together, the formulation provides support that helps ease the overall symptom load and may assist with maintaining functional stability during temporary episodes of heightened discomfort.


Key Context: Acute Symptom Management

The combination is relevant for episodic symptom management in adults and adolescents aged 12 and over, helping to manage symptom clusters that may become intense or disruptive. The medication is applied to provide supportive relief when symptoms interfere with routine activities, contributing to improved comfort during periods of heightened symptoms.

Regulatory References

  1. NIH MedlinePlus (via NCBI StatPearls) resource

Eligibility and Restrictions for Use

Who Can and Cannot Use Thomapyrin?

The population eligibility for Thomapyrin is defined by strict regulatory criteria based on age, pre-existing health conditions, and specific physiological states, as documented in official product labeling.

Contraindicated Populations (Must Not Use)

Contraindicated Population/Condition Restriction Basis
Age and Viral Illness Children under 12 years or those with chickenpox/flu-like illnesses (Reye's syndrome risk).
Gastrointestinal Disease Active or recurrent history of ulcers, bleeding, or perforation of the stomach or intestines.
Severe Organ Dysfunction Significant impairment of liver or kidney function, or severe heart muscle weakness (cardiac insufficiency).
Other Conditions Known hypersensitivity to any component (Acetylsalicylic acid, Acetaminophen, Caffeine, or salicylates) or a pathological tendency to bleed.

Restricted Eligibility and Conditional Use

Age and Development: Use is approved for adults and adolescents aged 12 and over who have no contraindications. It is contraindicated during the last trimester of pregnancy and not recommended while breastfeeding.

Conditional Use: The medicine requires special caution and may be restricted in populations with mild to moderate organ function impairment, certain chronic conditions like bronchial asthma, or a history of chronic stomach problems.

What should I know about interactions with other medicines?

Thomapyrin is a combination pain relief medicine containing acetylsalicylic acid (ASA), paracetamol, and caffeine. Due to its components, it can interact with several other medicines and products, which may increase the risk of side effects or alter the effectiveness of the medications.

Contraindicated and High-Risk Combinations

  • Anticoagulants (medicines to inhibit blood clotting) and medicines to prevent or dissolve a blood clot: Concurrent use is strictly contraindicated due to the significantly increased risk of bleeding from the acetylsalicylic acid component.
  • Alcohol: Simultaneous intake should be avoided, as it substantially increases the risk of gastrointestinal bleeding and may increase the risk of liver damage from the paracetamol component.
  • Other Painkillers (NSAIDs) and Corticosteroids: Taking Thomapyrin with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) or corticosteroids increases the risk of gastrointestinal ulceration or bleeding.

Other Documented Interactions

Interacting Product Category Potential Effect
Certain Antidepressants (SSRIs) Increased risk of gastrointestinal bleeding.
Thyroid Hormones Acetylsalicylic acid can potentially reduce the absorption of thyroid hormones.
Stimulants (e.g., coffee, tea) Caffeine content requires limiting additional intake to avoid overdose symptoms like nervousness, shakiness, or a rapid heartbeat.
Smoking Increases the rate at which caffeine is broken down (metabolized) in the liver.

Thomapyrin can also affect the results of certain laboratory tests, including those for determining uric acid and blood sugar levels. Patients should inform their doctor about taking this medicine before any such tests are performed.

Mechanism of Action

How Thomapyrin Works

Thomapyrin's pharmacodynamic mechanism is mediated by simultaneous action across distinct physiological pathways.

Mechanism of Prostaglandin Inhibition

This core mechanism involves one component irreversibly binding to Cyclooxygenase (COX) enzymes, while another component reversibly inhibits COX enzymes. This dual action suppresses the synthesis of prostaglandins, which are chemical mediators responsible for promoting nerve sensitization, ultimately reducing the frequency and volume of incoming signals from localized sites.

Central Nervous System (CNS) Signal Modulation

Another component acts as a non-selective antagonist of adenosine receptors in the brain, which effectively removes the natural inhibitory effect of adenosine on central neurons. This targeted pathway adjustment results in a modulation of the central nervous system's responsiveness to nociceptive input and elevates CNS excitability, contributing to the rapidity and magnitude of the resultant physiological change.

Synergistic Pathway Activation

The distinct, yet complementary, actions on both peripheral enzyme activity and central neuromodulation result in a broadened scope of physiological modulation. This mechanism induces a simultaneous change across multiple targeted pathways, resulting in a comprehensive adjustment to the body’s signaling dynamics.

Dosage and Administration Information

How to Use Thomapyrin: Official Administration Guidelines

Thomapyrin is a fixed-dose combination product intended solely for oral use via ingestion. The usage pattern is defined by specific parameters that govern dosing, frequency, and duration of use, as documented in the product's standardized information.


Administration and Dosage

Tablets may be taken by swallowing whole with sufficient liquid or after being dissolved or disintegrated in a small amount of water. The administration timing is flexible and may occur regardless of meals; however, taking the product on an empty stomach is noted to promote the onset of action.

Population Single Dose (Tablets) Minimum Interval Maximum Daily Dose
Adults (15 years) 1 to 2 tablets 4 to 8 hours 6 tablets
Adolescents (12-14 years) 1/2 to 1 tablet 4 to 8 hours 3 tablets

Usage Constraints

The medication is strictly intended for short-term, episodic use. General usage standards involve limits for continuous self-administration. Use typically does not exceed 3 to 4 days for pain or 3 days for fever. If symptoms persist beyond these time limits, medical consultation is recommended.

Adolescents aged 12 and over are approved for use, but specific limits apply to the 12-14 age group. Safety parameters indicate that other concurrently used products should not contain paracetamol to avoid exceeding the defined limits for that active ingredient.

Recent Clinical Evidence

Clinical Efficacy in Headache Treatment

Recent clinical evidence and meta-analyses consistently confirm the superior efficacy of the fixed-dose combination of Acetylsalicylic Acid (ASA), Paracetamol (Acetaminophen), and Caffeine (the components of Thomapyrin) compared to its individual components or the dual combination without caffeine. This combination is recognized as an effective over-the-counter treatment for acute migraine attacks and episodic tension-type headaches.

Key Findings from Trials

  • Faster and Greater Pain Relief: Studies demonstrate that the triple combination provides significantly faster and more complete pain relief than placebo. This enhanced effect is largely attributed to the addition of caffeine, which acts as an analgesic adjuvant, increasing the absorption and effectiveness of both ASA and Paracetamol.
  • Migraine Response: In patients with acute migraine of moderate-to-severe intensity, the combination has shown robust results. A review of randomized controlled trials indicated that patients taking the combination were significantly more likely to be pain-free or experience pain relief at two hours post-dosing compared to those taking a placebo. Furthermore, it demonstrated superior results for associated symptoms such as nausea, photophobia (light sensitivity), and phonophobia (sound sensitivity), and helped in the restoration of usual daily activities.
  • Comparison to Other Analgesics: When compared directly in clinical settings, the triple combination has been shown to be superior to single-ingredient treatments like ASA or Paracetamol alone, and even to the dual ASA and Paracetamol combination, particularly in achieving a faster time to 50% pain relief.

Tolerability

In clinical trials, the combination is generally well-tolerated when used occasionally at recommended doses. The most common adverse events reported are typically mild, such as gastrointestinal discomfort or nervousness, which are often associated with the individual components.

Frequently Asked Questions (FAQ)

Common questions about Thomapyrin (FAQ)

Q: How quickly does Thomapyrin usually start to relieve pain?

Studies and official information indicate that the formula, which contains caffeine, is specifically designed to enhance and accelerate the effect of the pain relievers. Product information states that the onset of pain relief may be up to 15 minutes faster compared to taking the individual active ingredients alone.

Q: Is Thomapyrin similar to standard aspirin-only tablets?

Thomapyrin is a fixed-dose combination product containing three active ingredients: acetylsalicylic acid (ASA, which is aspirin), paracetamol, and caffeine. It differs from standard aspirin-only tablets due to the inclusion of both paracetamol and caffeine, which the official description cites as an adjuvant, designed to enhance the speed and effectiveness of the pain relief.

Q: Can Thomapyrin be used for muscle aches?

Official product documentation focuses primarily on the symptomatic relief of acute headaches, including tension-type and migraine, and fever. The medicine is generally classified as a broad-spectrum analgesic, but specific indications beyond headaches and fever are not explicitly detailed in the product's primary use.

Q: Does Thomapyrin interact with common cold or flu medications?

Regulatory information addresses the risk of ingredient overlap, as many common cold and flu medications contain either paracetamol (acetaminophen) or non-steroidal anti-inflammatory drugs (NSAIDs). Official labeling states the necessity of ensuring that other products taken concurrently do not contain paracetamol or other NSAIDs due to the documented risk of ingredient overlap and increased side effects.

Q: What is the difference between Thomapyrin and acetaminophen (paracetamol)?

Thomapyrin is a combination analgesic containing three active ingredients: acetylsalicylic acid (ASA), paracetamol (acetaminophen), and caffeine. Paracetamol is only one of the three components. The combination is described in official sources as achieving a synergistic effect, which is cited to enhance the speed and effectiveness of the pain relief.

Q: Are there dietary restrictions mentioned in the official Thomapyrin documents?

Official documents advise that simultaneous intake of alcohol should be avoided due to the increased risk of gastrointestinal bleeding and potential liver damage. Intake of other caffeine-containing products (like coffee or tea) should also be limited to avoid symptoms of caffeine overdose, such as nervousness and shakiness.

Q: Can Thomapyrin affect kidney function in healthy individuals?

Regulatory labeling notes that renal dysfunction (kidney problems) is classified as a very rare adverse effect associated with this type of combination product. The medicine is officially contraindicated (should not be used) for individuals who have severe impairment of kidney function.

Q: How long can the pain relief effects of Thomapyrin last?

Official administration guidelines state that the minimum interval between doses for adults is 4 to 8 hours. Regulatory documents define the minimum interval between doses, which is the shortest period permitted before the product may be used again. The medicine is strictly intended for short-term, episodic use.

Q: Is Thomapyrin available in different strengths?

Official product information indicates that the medicine may be available in different formulations, such as Thomapyrin Classic and Thomapyrin Intensiv. These different formulations have slightly varying dosages of the active ingredients contained within the tablet.

Q: Are there any known issues combining Thomapyrin with high blood pressure medicines?

The acetylsalicylic acid (ASA) component is classified as a non-steroidal anti-inflammatory drug (NSAID). This class of medicines is described in some regulatory documents as potentially reducing the blood pressure-lowering effects of certain diuretics and other antihypertensive (high blood pressure) drugs.

Q: Is Thomapyrin appropriate for people over the age of 65?

Official eligibility is defined as adults and adolescents aged 12 and over who have no specific contraindications. Regulatory documents strictly limit the medicine to short-term, episodic use. The potential for long-term risks, including gastrointestinal, cardiovascular, and renal effects associated with components like paracetamol, has been noted in authoritative research regarding older populations.

Q: Why do some people experience ringing in their ears with medicines like Thomapyrin?

Ringing in the ears, known as tinnitus, is a documented side effect associated with the acetylsalicylic acid (ASA) component of the medicine. This effect is particularly noted when higher doses are used.

Q: Can Thomapyrin affect sleep patterns?

The medicine contains caffeine, a stimulant that can elevate central nervous system excitability. Agitation is listed in official documents as a rare adverse effect, which may potentially influence sleep patterns.

Q: Are there different formulas or variants of Thomapyrin available?

Official product information indicates that the medicine may be available in different formulations, such as Thomapyrin Classic and Thomapyrin Intensiv. These different variants have slightly varying dosages of the active ingredients contained within the tablet.

Q: Does Thomapyrin have potential interactions with herbal supplements?

Official documentation primarily addresses drug-drug interactions. However, official product information notes that, as the product contains acetylsalicylic acid (ASA), there is a regulatory concern for interactions with herbal supplements that may affect blood clotting.

Q: Does Thomapyrin contain lactose or gluten?

The Thomapyrin Intensiv formulation is documented in product literature to contain lactose as an excipient (an inactive substance). Excipient information for specific formulations is located in the official package leaflet.

Q: Does Thomapyrin contain codeine or other opioid ingredients?

The official composition of Thomapyrin is limited to three active ingredients: acetylsalicylic acid (ASA), paracetamol (acetaminophen), and caffeine. Opioid ingredients, such as codeine, are not components of the product.

How should Thomapyrin be stored and disposed of?

Official Storage and Disposal Instructions

Storage Requirements

The product must be stored in accordance with official labeling to maintain stability. The tablets must be kept out of the sight and reach of children as a standard safety measure. They require protection from environmental factors, meaning they should be stored below 30 C and kept in the original container to shield them from light and moisture. The medicine must not be used after the expiry date printed on the packaging.

Disposal Requirements

Unused or expired Thomapyrin must be disposed of according to local pharmaceutical waste regulations. The safest regulatory option is to return the medicine to a pharmacy or an authorized drug take-back program. It is prohibited to dispose of the medicine by flushing it down the toilet or placing it into regular household trash, as this prevents environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Thomapyrin found in:

A-Z Index: